antiarrhythmic drug testing carried out in the late reperfusion phase with lidocaine ( 1 mg/kg bolus followed by continuous infusion ) revealed 50 % efficacy at a dosage of 40 micrograms/kg/min , 100 % at 80 micrograms/kg/min , and 67 % at 120 mu/kg/min .
C0003195
antiarrhythmic drug
C0023660
lidocaine